These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1675602)

  • 21. [Controversies and trends in ulcer therapy. 2: Prevention of recurrence].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):743-8. PubMed ID: 7901948
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
    Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
    Novotný I; Díte P; Kunovská M; Münzová H
    Vnitr Lek; 2007 Oct; 53(10):1053-6. PubMed ID: 18072429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I've taken aspirin for years to prevent heart attack, and now I've developed an ulcer. My doctor told me to keep taking aspirin along with Prilosec. Why keep taking aspirin if it caused my ulcer?
    Mayo Clin Health Lett; 2012 Mar; 30(3):999. PubMed ID: 22550743
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention and treatment of gastric mucosal injury in patients taking low-dose aspirin].
    Satoh K; Sugano K
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():450-4. PubMed ID: 22519032
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE
    Am Fam Physician; 1986 Nov; 34(5):141-4. PubMed ID: 2877559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H2 blockers in the intensive care unit: ignoring the evidence? Telephone survey.
    Wyncoll DL; Roberts PC; Beale RJ; McLuckie A
    BMJ; 1997 Apr; 314(7086):1013. PubMed ID: 9112846
    [No Abstract]   [Full Text] [Related]  

  • 38. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [75 mg roxatidine nocte protects human gastric mucosa against 300 mg acetylsalicylic acid nocte].
    Simon B; Bergdolt H; Dammann HG; Müller P
    Z Gastroenterol; 1991 Nov; 29(11):599-601. PubMed ID: 1771935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.